ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00267683
Recruitment Status : Terminated (This trial was terminated due to low recruitment)
First Posted : December 21, 2005
Last Update Posted : March 4, 2016
Sponsor:
Information provided by (Responsible Party):
Novo Nordisk A/S

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : April 2006
  Actual Study Completion Date : April 2006